Perinatal Depression: A Guide to Detection and Management in Primary Care

References

1. 1.↵
   1. Woody CA,
   2. Ferrari AJ,
   3. Siskind DJ,
   4. Whiteford HA,
   5. Harris MG

   . A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord 2017;219:86–92.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Yin X,
   2. Sun N,
   3. Jiang N,
   4. et al

   . Prevalence and associated factors of antenatal depression: Systematic reviews and meta-analyses. Clin Psychol Rev 2021;83:101932.

   OpenUrl
3. 3.↵
   1. Wang Z,
   2. Liu J,
   3. Shuai H,
   4. et al

   . Mapping global prevalence of depression among postpartum women. Transl Psychiatry 2021;11:543.

   OpenUrl
4. 4.↵
   1. Shorey S,
   2. Chee CYI,
   3. Ng ED,
   4. Chan YH,
   5. Tam WWS,
   6. Chong YS

   . Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res 2018;104:235–48.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Shay M,
   2. MacKinnon AL,
   3. Metcalfe A,
   4. et al

   . Depressed mood and anxiety as risk factors for hypertensive disorders of pregnancy: a systematic review and meta-analysis. Psychol Med 2020;50:2128–40.

   OpenUrl
6. 6.↵
   1. Hu R,
   2. Li Y,
   3. Zhang Z,
   4. Yan W

   . Antenatal depressive symptoms and the risk of preeclampsia or operative deliveries: a meta-analysis. PloS One 2015;10:e0119018.

   OpenUrl
7. 7.↵
   1. Jacques N,
   2. de Mola CL,
   3. Joseph G,
   4. Mesenburg MA,
   5. da Silveira MF

   . Prenatal and postnatal maternal depression and infant hospitalization and mortality in the first year of life: a systematic review and meta- analysis. J Affect Disord 2019;243:201–8.

   OpenUrl
8. 8.↵
   1. Dadi AF,
   2. Miller ER,
   3. Mwanri L

   . Postnatal depression and its association with adverse infant health outcomes in low- and middle-income countries: a systematic review and meta-analysis. BMC Pregnancy Childbirth 2020;20:416.

   OpenUrlPubMed
9. 9.↵
   1. Khalifeh H,
   2. Hunt IM,
   3. Appleby L,
   4. Howard LM

   . Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry. Lancet Psychiatry 2016;3:233–42.

   OpenUrl
10. 10.↵
    1. Adane AA,
    2. Bailey HD,
    3. Morgan VA,
    4. et al

    . The impact of maternal prenatal mental health disorders on stillbirth and infant mortality: a systematic review and meta-analysis. Arch Womens Ment Health 2021;24:543–55.

    OpenUrl
11. 11.↵
    1. Johannsen BMW,
    2. Larsen JT,
    3. Laursen TM,
    4. Bergink V,
    5. Meltzer-Brody S,
    6. Munk-Olsen T

    . All-cause mortality in women with severe postpartum psychiatric disorders. Am J Psychiatry 2016;173:635–42.

    OpenUrl
12. 12.↵
    1. Vlenterie R,
    2. van Gelder MMHJ,
    3. Anderson HR,
    4. et al

    . Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis. Obstet Gynecol 2021;138:633–46.

    OpenUrl
13. 13.↵
    1. Grigoriadis S,
    2. VonderPorten EH,
    3. Mamisashvili L,
    4. et al

    . The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013;74:e321–e341.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Jarde A,
    2. Morais M,
    3. Kingston D,
    4. et al

    . Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry 2016;73:826–37.

    OpenUrl
15. 15.↵
    1. Fekadu Dadi A,
    2. Miller ER,
    3. Mwanri L

    . Antenatal depression and its association with adverse birth outcomes in low and middle-income countries: A systematic review and meta-analysis. PloS One 2020;15:e0227323.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Ghimire U,
    2. Papabathini SS,
    3. Kawuki J,
    4. Obore N,
    5. Musa TH

    . Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis. Early Hum Dev 2021;152:105243.

    OpenUrl
17. 17.↵
    1. El Marroun H,
    2. Jaddoe VWV,
    3. Hudziak JJ,
    4. et al

    . Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012;69:706–14.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Tichelman E,
    2. Westerneng M,
    3. Witteveen AB,
    4. et al

    . Correlates of prenatal and postnatal mother-to-infant bonding quality: a systematic review. PloS One 2019;14:e0222998.

    OpenUrl
19. 19.↵
    1. Kim S,
    2. Park M,
    3. Ahn S

    . The impact of antepartum depression and postpartum depression on exclusive breastfeeding: a systematic review and meta-analysis. Clin Nurs Res 2022;31:866–80.

    OpenUrl
20. 20.↵
    1. Xia M,
    2. Luo J,
    3. Wang J,
    4. Liang Y

    . Association between breastfeeding and postpartum depression: a meta- analysis. J Affect Disord 2022;308:512–9.

    OpenUrl
21. 21.↵
    1. Madigan S,
    2. Oatley H,
    3. Racine N,
    4. et al

    . A meta-analysis of maternal prenatal depression and anxiety on child socioemotional development. J Am Acad Child Adolesc Psychiatry 2018;57:645–57.e8.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Rogers A,
    2. Obst S,
    3. Teague SJ,
    4. et al

    . Association between maternal perinatal depression and anxiety and child and adolescent development: a meta-analysis. JAMA Pediatr 2020;174:1082–92.

    OpenUrl
23. 23.↵
    1. Power J,
    2. van IJzendoorn M,
    3. Lewis AJ,
    4. Chen W,
    5. Galbally M

    . Maternal perinatal depression and child executive function: a systematic review and meta-analysis. J Affect Disord 2021;291:218–34.

    OpenUrlPubMed
24. 24.↵
    1. Tirumalaraju V,
    2. Suchting R,
    3. Evans J,
    4. et al

    . Risk of depression in the adolescent and adult offspring of mothers with perinatal depression: a systematic review and meta-analysis. JAMA Netw Open 2020;3:e208783.

    OpenUrl
25. 25.↵
    1. Baird H,
    2. Harris RA,
    3. Santos HPJ

    . The Effects of maternal perinatal depression on child IQ: a systematic review. Matern Child Health J. 2023;27:1489–502.Published online June.

    OpenUrl
26. 26.↵
    1. Wang D,
    2. Li YL,
    3. Qiu D,
    4. Xiao SY

    . Factors influencing paternal postpartum depression: a systematic review and meta-analysis. J Affect Disord 2021;293:51–63.

    OpenUrl
27. 27.↵
    1. Ansari NS,
    2. Shah J,
    3. Dennis CL,
    4. Shah PS

    . Risk factors for postpartum depressive symptoms among fathers: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2021;100:1186–99.

    OpenUrl
28. 28.↵
    1. Bauer A,
    2. Knapp M,
    3. Parsonage M

    . Lifetime costs of perinatal anxiety and depression. J Affect Disord 2016;192:83–90.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Cox EQ,
    2. Sowa NA,
    3. Meltzer-Brody SE,
    4. Gaynes BN

    . The perinatal depression treatment cascade: baby steps toward improving outcomes. J Clin Psychiatry 2016;77:1189–200.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Noonan M,
    2. Doody O,
    3. Jomeen J,
    4. O’Regan A,
    5. Galvin R

    . Family physicians perceived role in perinatal mental health: an integrative review. BMC Fam Pract 2018;19:154.

    OpenUrl
31. 31.↵
    1. Ford E,
    2. Shakespeare J,
    3. Elias F,
    4. Ayers S

    . Recognition and management of perinatal depression and anxiety by general practitioners: a systematic review. Fam Pract 2017;34:11–9.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Ford E,
    2. Lee S,
    3. Shakespeare J,
    4. Ayers S

    . Diagnosis and management of perinatal depression and anxiety in general practice: a meta-synthesis of qualitative studies. Br J Gen Pract J Pract 2017;67:e538–e546.

    OpenUrl
33. 33.↵
    1. Branquinho M,
    2. Shakeel N,
    3. Horsch A,
    4. Fonseca A

    . Frontline health professionals’ perinatal depression literacy: a systematic review. Midwifery 2022;111:103365.

    OpenUrl
34. 34.↵
    1. Siu AL,
    2. Bibbins-Domingo K,
    3. Grossman DC

    , US Preventive Services Task Force (USPSTF)et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA 2016;315:380–7.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Ebell MH,
    2. Siwek J,
    3. Weiss BD,
    4. et al

    . Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract 2004;17:59–67.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Einarson A,
    2. Choi J,
    3. Einarson TR,
    4. Koren G

    . Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry Rev Can hiatry 2009;54:242–6.

    OpenUrl
37. 37.↵
    1. Baethge C,
    2. Goldbeck-Wood S,
    3. Mertens S

    . SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 2019;4:5.

    OpenUrl
38. 38.↵
    1. Cox JL,
    2. Holden JM,
    3. Sagovsky R

    . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry J Psychiatry 1987;150:782–6.

    OpenUrl
39. 39.↵
    1. O'Connor E,
    2. Rossom RC,
    3. Henninger M,
    4. Groom HC,
    5. Burda BU

    . Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2016;315:388–406.

    OpenUrlCrossRefPubMed
40. 40.↵
    ACOG Committee Opinion. 757: Screening for perinatal depression. Obstet Gynecol 2018;132:e208–e212.

    OpenUrlCrossRef
41. 41.↵
    1. Earls MF,
    2. Yogman MW,
    3. Mattson G,
    4. Rafferty J

    , Committee on psychosocial aspects of child and family health. Incorporating recognition and management of perinatal depression into pediatric practice. Pediatrics 2019;143:e20183259.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Levis B,
    2. Negeri Z,
    3. Sun Y,
    4. Benedetti A,
    5. Thombs BD

    , DEPRESsion Screening Data (DEPRESSD) EPDS Group. Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for screening to detect major depression among pregnant and postpartum women: systematic review and meta-analysis of individual participant data. BMJ 2020;371:m4022.

    OpenUrlAbstract/FREE Full Text
43. 43.↵
    1. McCabe-Beane JE,
    2. Segre LS,
    3. Perkhounkova Y,
    4. Stuart S,
    5. O’Hara MW

    . The identification of severity ranges for the Edinburgh Postnatal Depression Scale. J Reprod Infant Psychol 2016;34:293–303.

    OpenUrlCrossRef
44. 44.↵
    1. Dikmen-Yildiz P,
    2. Ayers S,
    3. Phillips L

    . Depression, anxiety, PTSD and comorbidity in perinatal women in Turkey: a longitudinal population-based study. Midwifery 2017;55:29–37.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Howard S,
    2. Witt C,
    3. Martin K,
    4. et al

    . Co-occurrence of depression, anxiety, and perinatal posttraumatic stress in postpartum persons. BMC Pregnancy Childbirth 2023;23:232.

    OpenUrl
46. 46.↵
    1. Matthey S,
    2. Fisher J,
    3. Rowe H

    . Using the Edinburgh postnatal depression scale to screen for anxiety disorders: conceptual and methodological considerations. J Affect Disord 2013;146:224–30.

    OpenUrl
47. 47.↵
    1. Matthey S,
    2. Valenti B,
    3. Souter K,
    4. Ross-Hamid C

    . Comparison of four self-report measures and a generic mood question to screen for anxiety during pregnancy in English-speaking women. J Affect Disord 2013;148:347–51.

    OpenUrlCrossRefPubMed
48. 48.↵
    1. Smith-Nielsen J,
    2. Egmose I,
    3. Wendelboe KI,
    4. Steinmejer P,
    5. Lange T,
    6. Vaever MS

    . Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety? BMC Psychol 2021;9:118.

    OpenUrl
49. 49.↵
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JB

    . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.

    OpenUrlCrossRefPubMedWeb of Science
50. 50.↵
    National Collaborating Centre for Mental Health (UK). Antenatal and postnatal mental health: clinical management and service guidance: updated edition. Published online 2020. Available at: https://www.nice.org.uk/guidance/cg192.
51. 51.↵
    1. Wang L,
    2. Kroenke K,
    3. Stump TE,
    4. Monahan PO

    . Screening for perinatal depression with the Patient Health Questionnaire depression scale (PHQ-9): A systematic review and meta-analysis. Gen Hosp Psychiatry 2021;68:74–82.

    OpenUrl
52. 52.↵
    1. Yonkers KA,
    2. Smith MV,
    3. Gotman N,
    4. Belanger K

    . Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder. Gen Hosp Psychiatry 2009;31:327–33.

    OpenUrlCrossRefPubMed
53. 53.↵
    COPE: Centre of Perinatal Excellence. Effective mental health care in the perinatal period: Australian clinical practice. 2023 revision. Published online June 2, 2023. Available at: https://www.cope.org.au/wp-content/uploads/2023/06/COPE_2023_Perinatal_Mental_Health_Practice_Guideline.pdf.
54. 54.↵
    1. Trost S,
    2. Beauregard J,
    3. Chandra G,
    4. et al

    . Pregnancy-related deaths: data from maternal mortality review committees in 36 US states, 2017–2019. Published online 2022. Available at: https://www.cdc.gov/reproductivehealth/maternal-mortality/docs/pdf/Pregnancy-Related-Deaths-Data-MMRCs-2017-2019-H.pdf.
55. 55.↵
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association; 2013.
56. 56.↵
    1. Bernstein IH,
    2. Rush AJ,
    3. Yonkers K,
    4. et al

    . Symptom features of postpartum depression: are they distinct? Depress Anxiety 2008;25:20–6.

    OpenUrlCrossRefPubMedWeb of Science
57. 57.↵
    1. Hendrick V,
    2. Altshuler L,
    3. Strouse T,
    4. Grosser S

    . Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety 2000;11:66–72.

    OpenUrlCrossRefPubMedWeb of Science
58. 58.↵
    1. Wisner KL,
    2. Peindl KS,
    3. Gigliotti T,
    4. Hanusa BH

    . Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999;60:176–80.

    OpenUrlCrossRefPubMed
59. 59.↵
    1. O'Connor E,
    2. Senger CA,
    3. Henninger ML,
    4. Coppola E,
    5. Gaynes BN

    . Interventions to prevent perinatal depression: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2019;321:588–601.

    OpenUrlCrossRefPubMed
60. 60.↵
    1. Curry SJ,
    2. Krist AH,
    3. Owens DK

    , US Preventive Services Task Forceet al. Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA 2019;321:580–7.

    OpenUrlCrossRefPubMed
61. 61.↵
    1. Martín-Gómez C,
    2. Moreno-Peral P,
    3. Bellón JA,
    4. et al

    . Effectiveness of psychological interventions in preventing postpartum depression in non-depressed women: a systematic review and meta-analysis of randomized controlled trials. Psychol Med . Published online March 82022;52:1001–13.

    OpenUrl
62. 62.↵
    1. Matthey S

    . Calculating clinically significant change in postnatal depression studies using the Edinburgh Postnatal Depression Scale. J Affect Disord 2004;78:269–72.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.↵
    1. Mao F,
    2. Sun Y,
    3. Wang J,
    4. Huang Y,
    5. Lu Y,
    6. Cao F

    . Sensitivity to change and minimal clinically important difference of Edinburgh postnatal depression scale. Asian J Psychiatr 2021;66:102873.

    OpenUrl
64. 64.
    1. Löwe B,
    2. Unützer J,
    3. Callahan CM,
    4. Perkins AJ,
    5. Kroenke K

    . Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004;42:1194–201.

    OpenUrlCrossRefPubMedWeb of Science
65. 65.
    1. Bauer-Staeb C,
    2. Kounali DZ,
    3. Welton NJ,
    4. et al

    . Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials. J Clin Epidemiol 2021;137:200–8.

    OpenUrl
66. 66.
    1. Kounali D,
    2. Button KS,
    3. Lewis G,
    4. et al

    . How much change is enough? Evidence from a longitudinal study on depression in UK primary care. Psychol Med 2022;52:1875–82.

    OpenUrl
67. 67.↵
    1. MacQueen GM,
    2. Frey BN,
    3. Ismail Z

    , CANMAT Depression Work Groupet al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: section 6. special populations: youth, women, and the elderly. Can J Psychiatry Rev Can hiatry 2016;61:588–603.

    OpenUrl
68. 68.↵
    1. Molenaar NM,
    2. Kamperman AM,
    3. Boyce P,
    4. Bergink V

    . Guidelines on treatment of perinatal depression with antidepressants: an international review. Aust N Z J Psychiatry 2018;52:320–7.

    OpenUrlCrossRefPubMed
69. 69.↵
    1. Cuijpers P,
    2. Franco P,
    3. Ciharova M,
    4. et al

    . Psychological treatment of perinatal depression: a meta-analysis. Psychol Med . Published online 2023;53:2596–608.

    OpenUrl
70. 70.↵
    1. Li L,
    2. Yue SW,
    3. Xu J,
    4. Qiao J,
    5. Redding SR,
    6. Ouyang YQ

    . Effectiveness of Internet-based psychological interventions for treating perinatal depression: a systematic review and meta-analysis. J Clin Nurs 2023;32:3087–101. Published online June.

    OpenUrl
71. 71.↵
    1. Viswanathan M,
    2. Middleton JC,
    3. Stuebe A,
    4. et al

    . Maternal, fetal, and child outcomes of mental health treatments in women: a systematic review of perinatal pharmacologic interventions. 2021; Agency for Healthcare Research and Quality (US).
72. 72.↵
    1. Wisner KL,
    2. Hanusa BH,
    3. Perel JM,
    4. et al

    . Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006;26:353–60.

    OpenUrlCrossRefPubMed
73. 73.↵
    Nortriptyline. In: Drugs and Lactation Database (LactMed). National Library of Medicine (US)2006.
74. 74.↵
    1. Berard A,
    2. Iessa N,
    3. Chaabane S,
    4. Muanda FT,
    5. Boukhris T,
    6. Zhao JP

    . The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol 2016;81:589–604.

    OpenUrlCrossRef
75. 75.↵
    1. Gao SY,
    2. Wu QJ,
    3. Sun C,
    4. et al

    . Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med 2018;16:205.

    OpenUrlCrossRefPubMed
76. 76.↵
    1. De Vries C,
    2. Gadzhanova S,
    3. Sykes MJ,
    4. Ward M,
    5. Roughead E

    . A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Saf 2021;44:291–312.

    OpenUrl
77. 77.↵
    1. Kallen B,
    2. Otterblad Olausson P

    . Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol Elmsford Toxicol 2006;21:221–2.

    OpenUrl
78. 78.↵
    1. Källén BAJ,
    2. Otterblad Olausson P

    . Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol Elmsford Toxicol 2003;17:255–61.

    OpenUrl
79. 79.↵
    Doxepin. In: Drugs and Lactation Database (LactMed). National Library of Medicine (US) 2006.
80. 80.↵
    1. Huang R,
    2. Yan C,
    3. Tian Y,
    4. et al

    . Effectiveness of peer support intervention on perinatal depression: A systematic review and meta-analysis. J Affect Disord 2020;276:788–96.

    OpenUrlPubMed
81. 81.↵
    1. Yan H,
    2. Wu Y,
    3. Li H

    . Effect of mindfulness-based interventions on mental health of perinatal women with or without current mental health issues: a systematic review and meta-analysis of randomized controlled trials. J Affect Disord 2022;305:102–14.

    OpenUrlCrossRefPubMed
82. 82.↵
    1. Morres ID,
    2. Tzouma NA,
    3. Hatzigeorgiadis A,
    4. et al

    . Exercise for perinatal depressive symptoms: a systematic review and meta- analysis of randomized controlled trials in perinatal health services. J Affect Disord 2022;298:26–42.

    OpenUrl
83. 83.↵
    1. Brown JVE,
    2. Wilson CA,
    3. Ayre K,
    4. et al

    . Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev 2021;2:CD013560.

    OpenUrlCrossRefPubMed
84. 84.↵
    1. Kaufman Y,
    2. Carlini SV,
    3. Deligiannidis KM

    . Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants. Ther Adv Psychopharmacol 2022;12:20451253211065859.

    OpenUrl
85. 85.↵
    1. Epperson CN,
    2. Rubinow DR,
    3. Meltzer-Brody S,
    4. et al

    . Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program. J Affect Disord 2023;320:353–9.

    OpenUrl
86. 86.↵
    1. Faden J,
    2. Citrome L

    . Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used? Ther Adv Psychopharmacol 2020;10:2045125320968658.

    OpenUrl
87. 87.↵
    1. Kolding L,
    2. Ehrenstein V,
    3. Pedersen L,
    4. et al

    . Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG Int BJOG 2021;128:1949–57.

    OpenUrl
88. 88.↵
    1. Rommel AS,
    2. Momen NC,
    3. Molenaar NM,
    4. et al

    . Antidepressant use during pregnancy and risk of adverse neonatal outcomes: a comprehensive investigation of previously identified associations. Acta Psychiatr Scand 2022;145:544–56.

    OpenUrl
89. 89.↵
    1. Lou ZQ,
    2. Zhou YY,
    3. Zhang X,
    4. Jiang HY

    . Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: A meta-analysis of cohort studies. Psychiatry Res 2022;316:114756.

    OpenUrl
90. 90.↵
    1. Anderson KN,
    2. Lind JN,
    3. Simeone RM,
    4. et al

    . Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry 2020;77:1246–55.

    OpenUrl
91. 91.↵
    1. Xing D,
    2. Wu R,
    3. Chen L,
    4. Wang T

    . Maternal use of antidepressants during pregnancy and risks for adverse perinatal outcomes: a meta-analysis. J Psychosom Res 2020;137:110231.

    OpenUrl
92. 92.↵
    1. Gumusoglu SB,
    2. Schickling BM,
    3. Vignato JA,
    4. Santillan DA,
    5. Santillan MK

    . Selective serotonin reuptake inhibitors and preeclampsia: a quality assessment and meta-analysis. Pregnancy Hypertens 2022;30:36–43.

    OpenUrl
93. 93.↵
    1. Wang XY,
    2. Ying XH,
    3. Jiang HY

    . Antidepressant use during pregnancy and the risk for gestational diabetes: a systematic review and meta-analysis. J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 2023;36:2162817.

    OpenUrl
94. 94.↵
    1. Kautzky A,
    2. Slamanig R,
    3. Unger A,
    4. Hoflich A

    . Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis. Acta Psychiatr Scand 2022;145:6–28.

    OpenUrl
95. 95.↵
    1. Jiang HY,
    2. Xu LL,
    3. Li YC,
    4. Deng M,
    5. Peng CT,
    6. Ruan B

    . Antidepressant use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis. J Psychiatr Res 2016;83:160–7.

    OpenUrl
96. 96.↵
    1. Grigoriadis S,
    2. VonderPorten EH,
    3. Mamisashvili L,
    4. et al

    . The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry 2013;74:e309–e320.

    OpenUrlCrossRefPubMedWeb of Science
97. 97.↵
    1. Hanley GE,
    2. Oberlander TF

    . The effect of perinatal exposures on the infant: antidepressants and depression. Best Pract Res Clin Obstet Gynaecol 2014;28:37–48.

    OpenUrlCrossRefPubMed
98. 98.↵
    1. Betcher HK,
    2. Wisner KL

    . Psychotropic treatment during pregnancy: research synthesis and clinical care principles. J Womens Health (Larchmt) 2020;29:310–8.

    OpenUrl
99. 99.↵
    1. Ng QX,
    2. Venkatanarayanan N,
    3. Ho CYX,
    4. Sim WS,
    5. Lim DY,
    6. Yeo WS

    . Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn: an update meta-analysis. J Womens Health (Larchmt) 2019;28:331–8.

    OpenUrlCrossRefPubMed
100. 100.↵
     1. Masarwa R,
     2. Bar-Oz B,
     3. Gorelik E,
     4. Reif S,
     5. Perlman A,
     6. Matok I

     . Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta- analysis, and network meta-analysis. Am J Obstet Gynecol 2019;220:57.e1–e1-57.e13.

     OpenUrl
101. 101.↵
     1. Grigoriadis S,
     2. Vonderporten EH,
     3. Mamisashvili L,
     4. et al

     . Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ 2014;348:f6932.

     OpenUrlCrossRefPubMed
102. 102.↵
     1. Munk-Olsen T,
     2. Bergink V,
     3. Rommel AS,
     4. Momen N,
     5. Liu X

     . Association of persistent pulmonary hypertension in infants with the timing and type of antidepressants in utero. JAMA Netw Open 2021;4:e2136639.

     OpenUrl
103. 103.↵
     1. Prady SL,
     2. Hanlon I,
     3. Fraser LK,
     4. Mikocka-Walus A

     . A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring’s outcomes. Arch Womens Ment Health 2018;21:127–40.

     OpenUrlCrossRefPubMed
104. 104.↵
     1. Rommel AS,
     2. Bergink V,
     3. Liu X,
     4. Munk-Olsen T,
     5. Molenaar NM

     . Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review. J Clin Psychiatry 2020;81:19r12965.

     OpenUrl
105. 105.↵
     1. Brown HK,
     2. Hussain-Shamsy N,
     3. Lunsky Y,
     4. Dennis CLE,
     5. Vigod SN

     . The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: a systematic review and meta-analysis. J Clin Psychiatry 2017;78:e48–e58.

     OpenUrlCrossRef
106. 106.↵
     1. Vega ML,
     2. Newport GC,
     3. Bozhdaraj D,
     4. Saltz SB,
     5. Nemeroff CB,
     6. Newport DJ

     . Implementation of advanced methods for reproductive pharmacovigilance in autism: a meta-analysis of the effects of prenatal antidepressant exposure. Am J Psychiatry 2020;177:506–17.

     OpenUrl
107. 107.↵
     1. Jiang HY,
     2. Peng CT,
     3. Zhang X,
     4. Ruan B

     . Antidepressant use during pregnancy and the risk of attention-deficit/hyperactivity disorder in the children: a meta-analysis of cohort studies. BJOG Int BJOG 2018;125:1077–84.

     OpenUrl
108. 108.↵
     1. Morales DR,
     2. Slattery J,
     3. Evans S,
     4. Kurz X

     . Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations. BMC Med 2018;16:6.

     OpenUrl
109. 109.↵
     1. Brown HK,
     2. Ray JG,
     3. Wilton AS,
     4. Lunsky Y,
     5. Gomes T,
     6. Vigod SN

     . Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA 2017;317:1544–52.

     OpenUrlCrossRef
110. 110.↵
     1. Uguz F

     . A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther 2021;28:e118–e126.

     OpenUrl
111. 111.↵
     1. Wald J,
     2. Henningsson A,
     3. Hanze E,
     4. et al

     . Allopregnanolone concentrations in breast milk and plasma from healthy volunteers receiving brexanolone injection, with population pharmacokinetic modeling of potential relative infant dose. Clin Pharmacokinet 2022;61:1307–19.

     OpenUrl
112. 112.↵
     1. Orsolini L,
     2. Bellantuono C

     . Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol 2015;30:4–20.

     OpenUrlCrossRefPubMed
113. 113.↵
     Venlafaxine. In: Drugs and Lactation Database (LactMed). National Library of Medicine (US); 2006.
114. 114.↵
     Duloxetine. In: Drugs and Lactation Database (LactMed). National Library of Medicine (US); 2006.
115. 115.↵
     1. Xiao M,
     2. Hu Y,
     3. Huang S,
     4. Wang G,
     5. Zhao J,
     6. Lei J

     . Prevalence of suicidal ideation in pregnancy and the postpartum: A systematic review and meta-analysis. J Affect Disord 2022;296:322–36.

     OpenUrl
116. 116.↵
     1. Ayers S,
     2. Bond R,
     3. Webb R,
     4. Miller P,
     5. Bateson K

     . Perinatal mental health and risk of child maltreatment: A systematic review and meta-analysis. Child Abuse Negl 2019;98:104172.

     OpenUrl
117. 117.↵
     1. Balbierz A,
     2. Bodnar-Deren S,
     3. Wang JJ,
     4. Howell EA

     . Maternal depressive symptoms and parenting practices 3-months postpartum. Matern Child Health J 2015;19:1212–9.

     OpenUrlCrossRefPubMed